Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • Nora AI
  • About Us
    • Our Coverage
    • Team
Regulatory press release

CS MEDICA A/S Evaluates Pre-IPO Share Distribution for CANNORDIC Stock Spin-off

Read the release

CS MEDICA Aims to Strengthen Shareholder Bonds with Pre-IPO Share Distribution for CANNORDIC in Germany

CS MEDICA A/S, a pioneering MedTech company specializing in innovative substance-based medical devices containing bioactive CBD, announced on June 10, 2024, its plans to spin off stocks and list its subsidiary CANNORDIC A/S on the German Stock Market (Intention to Float).

Today, the company announces its evaluation of the possibility of distributing CANNORDIC shares to existing CS MEDICA shareholders ahead of the planned initial public offering (IPO) in 2024, approved at the Extraordinary General Meeting (EGM) on June 28, 2024.

With the IPO of its subsidiary CANNORDIC on the horizon, CS MEDICA is exploring pre-rights share allocations to enhance value and show appreciation to its current shareholders. This approach aims to bolster CS MEDICA's financial strength while acknowledging those who have supported the company's journey.

Lone Henriksen, CEO of CS MEDICA, commented on the initiative: "Our exploration of pre-IPO share distribution is not just about protecting our share and value our shareholders. We see this as an opportunity to lay a stronger foundation for CANNORDIC with a shareholder base before the public listing this year's fall, ensuring continuity and stability in our growth track."
 

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.